{"filings":[{"id":95580,"accession_number":"0001803599-26-000126","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-05-01T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Director Bilge Ogut resigns after GBL reduces Concentrix stake below nomination threshold","event_type":"leadership","confidence":"high","bullets":["Bilge Ogut resigned from Concentrix Board effective April 29, 2026.","Resignation triggered by GBL's beneficial ownership falling below 50% of shares issued in Webhelp acquisition.","GBL entered a transaction on April 29, 2026 that reduced its stake below the Board Nomination Threshold.","GBL's nomination right was under the March 29, 2023 Investor Rights Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108746,"accession_number":"0001803599-26-000092","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Concentrix stockholders approve 3.7M share increase to 2020 equity plan","event_type":"other_material","confidence":"high","bullets":["Amendment to 2020 Stock Incentive Plan adds 3,700,000 shares, approved at March 25, 2026 Annual Meeting.","Total shares available for issuance under Plan increased to 4,469,067.","Stockholders elected nine directors, ratified Ernst & Young as auditor, and approved say-on-pay."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108745,"accession_number":"0001803599-26-000084","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-03-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q1 revenue up 5.4% but GAAP EPS drops 68% to $0.33, margins shrink","event_type":"earnings","confidence":"high","bullets":["Revenue $2,500.4M (+5.4% YoY); operating income $118.6M (-29.8%); GAAP EPS $0.33 (-68.3%).","Non-GAAP operating income $295.0M (-8.2% YoY); Non-GAAP EPS $2.61 (-6.5%).","Adjusted EBITDA $348.2M (13.9% margin, -190bps YoY); cash used in ops $83.2M.","Declared $0.36 quarterly dividend payable May 5; repurchased 1M shares for $42M in Q1."],"consensus_eps_estimate":null,"consensus_eps_actual":0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":2500391000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108744,"accession_number":"0001803599-26-000080","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-03-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Concentrix expands AR securitization facility to $750M, extends to March 2028","event_type":"debt","confidence":"high","bullets":["Commitment increased from $700M to $750M under receivables securitization facility.","Termination date extended from Jan 14, 2027 to March 20, 2028.","Sixth Amendment dated March 20, 2026; PNC Bank remains administrative agent.","Borrower is subsidiary Concentrix Receivables, Inc.; Concentrix acts as servicer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108743,"accession_number":"0001803599-26-000074","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Concentrix issues $600M 6.5% senior notes due 2029, redeems $600M of 6.65% notes due 2026","event_type":"debt","confidence":"high","bullets":["Issued $600M aggregate principal of 6.500% Senior Notes due March 1, 2029 in a registered public offering.","Net proceeds used with other funds to redeem $600M of its 6.650% Senior Notes maturing August 2, 2026.","Interest on the new notes payable semi-annually on March 1 and September 1, beginning September 1, 2026.","Interest rate subject to adjustment upon rating changes by Moody's, S&P or Fitch.","Notes are redeemable at Concentrix's option, with a par call date of February 1, 2029."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108742,"accession_number":"0001803599-26-000068","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-02-13T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Concentrix prices $600M of 6.500% senior notes due 2029; will redeem $600M of existing 6.650% notes","event_type":"debt","confidence":"high","bullets":["Issued $600M principal of 6.500% Senior Notes due 2029; priced Feb 12, 2026.","Proceeds to redeem $600M of 6.650% Senior Notes due Aug 2, 2026; closing expected Feb 24.","Existing 2026 notes had $800M outstanding; after redemption $200M will remain.","Offering led by BofA Securities and J.P. Morgan as joint book-running managers.","New notes extend maturity from 2026 to 2029 with a slightly lower coupon."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108741,"accession_number":"0001803599-26-000003","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2026-01-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix reports Q4 GAAP loss of $23.85/sh on $1.5B goodwill impairment; FY rev +2.2%","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $2,552.9M (+4.3% YoY); FY revenue $9,825.8M (+2.2% YoY).","Q4 GAAP operating loss $1,382.4M includes $1,523.3M non-cash goodwill impairment; FY op loss $918.2M.","Non-GAAP diluted EPS Q4 $2.95 (vs $3.26); FY $11.22 (vs $11.42); margins declined 90-170 bps.","FY adjusted free cash flow $626.4M; cash from operations $807.0M; net debt reduced $184M.","FY returned $258M to shareholders; Q4 dividend $0.36 payable Feb 10, 2026; share repurchase auth $438.6M."],"consensus_eps_estimate":null,"consensus_eps_actual":-20.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":9825771000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141915,"accession_number":"0001803599-25-000143","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-09-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q3 revenue above guidance; raises full-year growth outlook, increases dividend","event_type":"earnings","confidence":"high","bullets":["Revenue $2,483M (+4.0% YoY), above guidance; constant-currency growth 2.6%.","Non-GAAP diluted EPS $2.78 vs $2.87 YoY; GAAP EPS $1.34 vs $0.25.","Adjusted EBITDA $359M (14.5% margin), down from $388M (16.3%) YoY.","Dividend raised to $0.36/share (+8%), payable Nov 4 to holders of record Oct 24.","Repurchased 800k shares for $42.2M in Q3; $495.1M remaining authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":3.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":7272846000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159845,"accession_number":"0001803599-25-000127","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-06-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Concentrix Q2 rev $2.417B (+1.5% YoY) beats guidance; raises FY outlook; EPS $0.63 GAAP, $2.70 non-GAAP","event_type":"earnings","confidence":"high","bullets":["Revenue $2,417M (+1.5% YoY) beat guidance; full-year growth outlook raised.","GAAP diluted EPS $0.63 vs $0.98 YoY; non-GAAP diluted EPS $2.70 vs $2.69 (+0.4%).","Adjusted EBITDA $357M (14.8% margin) down 5.9% YoY on temporary program pauses.","Generated $200M adjusted free cash flow in Q2; on track for $625-650M full year.","Board declared $0.33275/sh dividend payable Aug 5, 2025; $45M in share repurchases in Q2."],"consensus_eps_estimate":2.803,"consensus_eps_actual":1.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":4789593000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159844,"accession_number":"0001803599-25-000123","cik":1803599,"company_name":"Concentrix Corp","ticker":"CNXC","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Olivier Duha resigns from Concentrix board for personal reasons","event_type":"leadership","confidence":"high","bullets":["Olivier Duha notified the Board of his resignation effective June 3, 2025.","Resignation was for personal reasons, not due to any disagreement with the Company.","Mr. Duha also stepped down from all board committees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}